Sign in

CIK 0001228627 · Non-accelerated filer<br>Smaller reporting company

Opus Genetics, Inc.

Sign in to watch
Ticker
IRD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
113516358
Phone
(984) 884-6030
Business address
8 DAVIS DRIVE, SUITE 220, DURHAM, NC, 27713
Former names
Ocuphire Pharma, Inc., REXAHN PHARMACEUTICALS, INC., CORPORATE ROAD SHOW DOT COM INC, FERRARO FRANK
  1. 4 Grant or award Director acquired 67,000 shares (grant or award)
  2. 4 Grant or award Director acquired 31,188 shares (grant or award)
  3. 4 Grant or award Director acquired 23,643 shares (grant or award)
  4. 4 Grant or award Director acquired 21,127 shares (grant or award)
  5. 4 Grant or award Director acquired 42,507 shares (grant or award)
  6. 4 Open-market buy Director bought 164,000 shares at an average $1.97 ($323,693)
  7. 4 Open-market sale Director sold 4,000,000 shares at $2.15 ($8,600,000)
  8. 4/A Shares withheld for taxes Chief Executive Officer gave up 30,350 shares (to pay taxes)
  9. 4 Shares withheld for taxes Chief Executive Officer gave up 30,350 shares (to pay taxes)
  10. 4 Shares withheld for taxes President gave up 23,795 shares (to pay taxes)
  11. 4 Grant or award Chief Financial Officer acquired 200,000 shares (grant or award)
  12. 3 Insider Initial Statement of Ownership
  13. 4 Grant or award Director acquired 869,565 shares (grant or award)
  14. 4 Grant or award Director acquired 86,956 shares (grant or award)
  15. 4 Conversion Director acquired 6,927,419 shares (conversion)
  16. 4 Grant or award Director acquired 79,504 shares (grant or award)
  17. 4 Grant or award Director acquired 79,504 shares (grant or award)
  18. 4 Grant or award Director acquired 79,504 shares (grant or award)
  19. 4 Grant or award Director acquired 79,504 shares (grant or award)
  20. 4 Grant or award Director acquired 79,504 shares (grant or award)

Page 3 of 21 · 403 filings